Novavax
Novavax on to new highsNVAX could not even break and retest the old Resistance from August, it also formed a nice setup, where the break was also a break of the downtrendline at the same time.
Todays Session retested both, now forming a double support, which could allow us some decent gains...
Vistagen (VTGN): Long-term Game-changer* This is not financial advice. This is my non-expert opinion. *
Vistagen ( NASDAQ:VTGN ) is a clinical stage biopharmaceutical company with long-term potential. I believe it's technology is similarly game-changing the way I believe NanoFlu for Novavax is (www.novavax.com) ( ). It could have positive outcomes for the world. I hope that their tech comes to fruition. Their pipeline includes Neuroactive nasal sprays that don't involve benzodiazepine and its associated side effects. I hope they succeed because it could change the way patients with anxiety or depression-related disorders are treated.
Vistagen: www.vistagen.com
Pipeline: www.vistagen.com
PH94B Neuroactive Nasal Spray is their most advanced candidate, which is currently in Stage 3 clinical trials. I encourage anyone who wants to do their own research. This animated demonstration was very informative for me www.youtube.com
Keep an eye out for this company.
I can make this same trade several timeRSI same resistance
UPTREND trend line
Until up trend huge break out!!
NOVAVAXif market keep is bullish euphorique structure, we are close to start the 3 wave that is extensive.
fundamental:
with covid trubbles and vaccination approval we can see that the probable futur trend will be bullish.
investor tend to go with hot stocks or easy to guest safe heaven sector, in the case of a global pendemie the one industry that cannot suffer from this is the medical and pharmacetical ones.
therfore the probability of a 3 wave arround the corner is really high.
also the wave 2 bounce from the 0.618 golden fib ratio, and wave 2 and 4 tend way more that just often to bounce from fib retracement. guessing a probal wave three from past support and resistance and using again the 0.618 to se were wave 4 should bounce at we have a strong probability to succes this trade.
as we know fib retracement tend to magicaly worked as resistance and support since so many investor/trader have orders at those levels.
entering now in the trade give you a stop loss at 80 so that would be 47 dollar risk/per share to a potential 120 dollar reward/ per share.
i don't know about you but i lile those kind of 3:1 reward to risk ratio.
best regards, patryck trader at richmonstocks funds.
novavax it will gain againnovavax technically is giving a good entry with stop loss
if the news get well it well touch the sky
like follow and share if it was usefull
novavax daily chart / update 1Yesterday's close was positive +2% as we wanted to hold the support and uptrend .
today we continue for the same scenario we want whatever possitive close again.
My first pt if we have good news is 300usd.
[NVAX] Still holding - Novavax is first "safe" COVID vaccineThis proved to the market and world governments that their nanotechnology is superior and that it works. Next stop, flu vaccine. I'm holding.
Disclaimer: Not financial advice. Just my opinion. See my related posts.
Source: www.cnn.com
MRNA- Leader in the vaccine race. Ladder buy to avoid the riskModerna is the first company to start the phase 3 trial in July and could have the supply ready earliest by Oct and accelerated approval earliest by December, according to Nami Sumida/BioPharma Dive and morningstar.
Other competitors are scheduled to have accelerated approval the earliest around early 2021.
[NVAX] Novavax: Preliminary studies produce promising resultsPreliminary studies on coronavirus vaccines have produced promising results.
I'm still a believer in their technology. Check out my previous NVAX posts and/or the first one. They have a promising technology that could revolutionize the vaccine industry. We (humanity) are already very behind in how we produce vaccines AKA using chicken eggs. So Novavax will hopefully pave the way for vaccines going forward.
Things to watch even after COVID-19:
- NanoFlu™
- ResVax™
- Recombinant Nanoparticle Vaccine Technology
- Matrix-M™ Adjuvant Technolog
TL;DR - To the moon and (probably) back lol
*Note: This is pure speculation and my own opinion*
NY Times: www.nytimes.com
CNBC: www.cnbc.com
[NVAX] Novavax: Update - 1.6 billion funded!I still believe NVAX has a lot of potential and I'll say it again. My idea is clear that its NanoParticle and Matrix-M Adjuvant tech makes it a prime candidate for a COVID-19 vaccines. Even if it doesn't make it first (or ever), it still has major potential for the seasonal influenza (w/ NanoFlu) and its Respiratory Syncytial Virus (RSV) vaccine. Check out my original post that is linked.
Today's News:
1. www.cnbc.com
2. www.fool.com
NOVAVAX - long term targetsThese are my thoughts on Novavax. They are meant to give you an idea, not trading advice.
As written in the textbooks, gaps in a downtrend always get filled in an uptrend. We already filled gap 1. I believe it's time to start filling gap 2, witch is gigantic. Novavax is receiving a lot of financial support for making a Covid19 vaccin, so expectations are high for now. It's one of the stronger stocks in the market at this moment, working together with Biotechnology.
As you can see on the charts, we have formed a similar pattern as we did in April 2020.
I don't know how fast gap 2 can get filled, but as soon as we started filing gap 1, things skyrocketed.
I'm very excited to see how this will play out, and I hope it can help you.
Please note that Novavax is a very volatile stock, things can change very fast over night.
Be careful when entering your position in this stock!
NVAX Long - $150 Target?I've been following NVAX since price was at $12. Fundamentally they have one of the most promising COVID vaccines and their Nano Flu shot beat Sanify's flu shot, whos been a market majority holder in that aspect.
Technically, we've tapped that $150+ zone 8 out of the last 9 fast rises over since the company IPO'd in 1996. Each of the rises have been driven by pandemic viruses..ie, swine flu, bird flu, H1N1, etc.
We have 4 days until the quarterly candle closes. If we close strong, we'd of closed above the coral, and momentum and RSI are correlating. I think we will see a short term sell off at the psychological $100 level. How much? I could see $80-$85 be a good rebuy zone to push price up to t $125 then $150. Buyers at $80, will probably be looking for a double on their investment which would put price at $160.
Let me know what you think!
Novavax (NVAX) stock price is on track...for now [LONG]Just re-iterating my previous assertion (guess) that NVAX is on course for massive gains in the long-term. Doesn't mean it's a great company but this pandemic has initiated a similar pattern in the past. They have several great developments in the works: NanoFlu, RSV F, and a COVID-19 vaccine candidate. See my previous posts especially the related one.
This is purely speculation based on their pipeline. This is not financial advice.
Novavax, Inc. (NVAX) long.All description on the chart.
Please, don't forget to like and follow.
Thank you.
Novavax Technical and Fundamental AnalysisTechnical Analysis - Check/wait if one of the supports will not be broken before buying
On a daily chart there might be a Bottom Saucer or Rounding Reversal Pattern
Fundamental News:
Novavax (NASDAQ:NVAX) is a clinical-stage biotechnology company focused on the discovery, development and commercialisation of vaccines and adjuvants. Through its recombinant nanoparticle vaccine technology, it produces vaccine candidates to respond to both known and newly emerging diseases.
Novavax topped Wall Street expectations for the first quarter when it reported a loss of 58 cents per share on revenue of $3.4 million earlier this month. Analysts were expecting a loss of 69 cents per share and revenue of $1.9 million.
More importantly, the biotech company announced in its earnings release that the Oslo-based nonprofit Coalition for Epidemic Preparedness Innovations will invest $384 million to advance the clinical development of its SARS-CoV-2 vaccine candidate, NVX-CoV2373.
Novavax plans to start human trials in May with preliminary results expected in July.
Novavax (NVAX): Tell me about my Schiff!I'm bull-ish on Novavax (see Related Idea). I think their approach to the COVID-19 vaccine is promising - their recombinant nanoparticle vaccine technology and Matrix-M adjuvant. They also have positive long-term prospects with their proprietary NanoFlu candidate. This is the big one to me. It's unclear whether COVID-19 becomes seasonal or not but influenza is established and recurring. It fact, it's becoming more difficult to handle with every year. The strains are becoming more advanced and unpredictable. Whether or not Novavax can produce a profitable candidate, I simply don't know. I believe that their patented tech is promising.
Novavax might not produce a COVID vaccine before its competitors (or at all) but they continue to demonstrate their technology and approach works. Example: ir.novavax.com
That being said, tell me about this random Schiff I plotted :)
Matrix-M Adjuvant: novavax.com
NanoFlu Phase 3 topline data: novavax.com
RSV F Vaccine: novavax.com
Novavax $NVAX#Novavax hit the weekly 100SMA and stalling and forming double top. It may pull back on next week.
NVAX - Bullish Swing TradeI am a little late publishing this chart, I entered the trade on Friday. NVAX has strong support at around $1.96 and has bounced there several times.
My target is $2.34 and depending on how strong NVAX looks I may just take a partial there and trail my stop behind the rest.
